Cysteine‐Specific Multifaceted Bioconjugation of Peptides and Proteins Using 5‐Substituted 1,2,3‐Triazines
Advanced Science · 2024-06 · 11 (21)
DOI: 10.1002/advs.202308491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 11.03.2024. Verfasst von Quan Zuo und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and P…. Hauptthemen laut MEDLINE: Cysteine, Triazines, Peptides, Proteins. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Program for Chang-Jiang Scholars and Innovative Research Team in University, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.
Abstract (Originalsprache)
Peptide and protein postmodification have gained significant attention due to their extensive impact on biomolecule engineering and drug discovery, of which cysteine‐specific modification strategies are prominent due to their inherent nucleophilicity and low abundance. Herein, the study introduces a novel approach utilizing multifunctional 5‐substituted 1,2,3‐triazine derivatives to achieve multifaceted bioconjugation targeting cysteine‐containing peptides and proteins. On the one hand, this represents an inaugural instance of employing 1,2,3‐triazine in biomolecular‐specific modification within a physiological solution. On the other hand, as a powerful combination of precision modification and biorthogonality, this strategy allows for the one‐pot dual‐orthogonal functionalization of biomolecules utilizing the aldehyde group generated simultaneously. 1,2,3‐Triazine derivatives with diverse functional groups allow conjugation to peptides or proteins, while bi‐triazines enable peptide cyclization and dimerization. The examination of the stability of bi‐triazines revealed their potential for reversible peptide modification. This work establishes a comprehensive platform for identifying cysteine‐selective modifications, providing new avenues for peptide‐based drug development, protein bioconjugation, and chemical biology research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Xian Nong Tan Street, Beijing, 100050, P.…
- Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences and Research Unit of Peptide Science, Chinese Academy of Medical Sciences, Lanzhou University, 199 West Donggang Road…
ORCID-Profile: Wangsheng Sun, Rui Wang
Förderung
- National Natural Science Foundation of China
- Program for Chang-Jiang Scholars and Innovative Research Team in University
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Zuo, Q., Li, Y., Lai, X., Bao, G., Chen, L., He, Z., Song, X., E, R., Wang, P., Shi, Y., Luo, H., Sun, W., & Wang, R. (2024). Cysteine‐Specific Multifaceted Bioconjugation of Peptides and Proteins Using 5‐Substituted 1,2,3‐Triazines. Advanced Science, 11(21). https://doi.org/10.1002/advs.202308491
Vancouver
Zuo Q, Li Y, Lai X, Bao G, Chen L, He Z, et al. Cysteine‐Specific Multifaceted Bioconjugation of Peptides and Proteins Using 5‐Substituted 1,2,3‐Triazines. Advanced Science. 2024;11(21). doi:10.1002/advs.202308491
BibTeX
@article{Zuo2024,
author = {Zuo, Quan and Li, Yiping and Lai, Xuanliang and Bao, Guangjun and Chen, Lu and He, Zeyuan and Song, Xinyi and E, Ruiyao and Wang, Pengxin and Shi, Yuntao and Luo, Huixin and Sun, Wangsheng and Wang, Rui},
title = {Cysteine‐Specific Multifaceted Bioconjugation of Peptides and Proteins Using 5‐Substituted 1,2,3‐Triazines},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {21},
doi = {10.1002/advs.202308491}
}
EUVIMED